DIRS.INFO The most relevant business & tech news

CNN —Israeli forces last week launched another military operation on Gaza’s largest hospital, Al-Shifa, bringing the sprawling medical facility north of the enclave back into the spotlight. Here’s what we know:Why are the Israeli forces raiding Al-Shifa again? Palestinian residents leave the area with a few items after Israeli forces besiege the Al-Shifa hospital with tanks and heavy gunfire in Gaza City, Gaza on March 18, 2024. Dawoud Abo Alkas/Anadolu/Getty ImagesResidents of the area around Al-Shifa told CNN there was heavy firing in the vicinity. Meanwhile a doctor who cared for patients trapped inside Al-Shifa told CNN he fears two severely malnourished siblings will not survive due to lack of care and medication.

Persons: Shifa, ”, Yoav Gallant, Gallant, Israel, Dawoud Abo, –, Mohammad Al Shawwa, Al Shawwa, “, ” Al Shawwa, Al Shawwa’s, Dr Ali Alghaliz, Rafiq Dughmosh, Rafif Dughmosh, Alghaliz, Mahmoud, Rafiq, “ Rafiq, Dr Ali, ” Alghaliz, Tedros Adhanom Ghebreyesus, ” Ghebreyesus, Jake Sullivan, Lloyd Austin, Jacquelyn Martin, ” Sullivan, Samantha Power Organizations: CNN, Israeli, Israel Defense Forces, Al, United Nations, IDF, Defense Ministry, Hamas, Islamic Jihad, Shifa, Dawoud Abo Alkas, Getty, Islamic, Al Ahli Baptist Hospital, Aid, Health Organization, WHO, National, US, Pentagon, US Agency for International Development, USAID Locations: Al, Gaza City, Gaza, Israel, “, –, Anadolu, Al Ahli, Israel’s, Shifa, Rafah, ”

☆ Exclusive: UK probes Novo's Ozempic, weight-loss drug Saxenda over suicidal, self-harming thoughts
▼ + stars: | 2023-07-26 | by ( Maggie Fick | ) www.reuters.com time to read: +4 min

Saxenda is Novo's older GLP-1 drug and has lower effectiveness than its newer obesity treatment Wegovy, which contains semaglutide. Novo told Reuters it had received a request on Monday from the MHRA about the agency's review of potential suicidal and self-harming thoughts related to GLP-1 drugs. The MHRA said AstraZeneca's GLP-1 drug for type 2 diabetes, called exenatide and marketed as Bydureon, was also included in the review. The MHRA said that two other GLP-1 drugs, Sanofi's (SASY.PA) lixisenatide and Eli Lilly's (LLY.N) dulaglutide, were also included. It is also investigating GLP-1 drugs for possible risk of thyroid cancer.

Persons: Novo, AstraZeneca's GLP, lixisenatide, Eli Lilly's, Sanofi, Eli Lilly, liraglutide, Alison Cave, Novo's, MHRA, Ozempic, GLP, Maggie Fick, Josephine Mason, Mark Potter, Jane Merriman Organizations: Novo Nordisk, European Union, The Medicines, Healthcare, Agency, Reuters, AstraZeneca, European Medicines Agency, Thomson Locations: Britain, Europe, United States

☆ Fact Check-No evidence COVID-19 mRNA vaccines are significant contributing factor to UK’s 30,000 excess cardiovascular deaths
▼ + stars: | 2023-01-24 | by ( Reuters Fact Check | ) www.reuters.com time to read: +5 min

Millions of people have viewed a BBC News interview with a British cardiologist who used the broadcast to spread misinformation about COVID-19 vaccines. Malhotra cites the British Heart Foundation (BHF) for reporting 30,000 excess cardiovascular deaths “during the pandemic or since the pandemic”. A BHF spokesperson told Reuters that there were indeed 30,000 excess deaths involving ischaemic heart disease (IHD) in England between March 2020 and August 2022. Reuters has addressed similar claims linking COVID-19 vaccines with excess mortality (here, here and here), cardiac arrests (here, here and here), and other heart issues. Experts say the 30,000 excess cardiovascular deaths reported since the beginning of the pandemic are due to COVID-19 infection and issues with healthcare services.

Search resuls for: "Dr Ali"

3 mentions found